In addition to the availability of many therapies that target HuR, gaining a comprehensive understanding of HuR’s diverse activities could lead to the development of new and particularly therapeutic strategies for various diseases, such as inflammatory disorders and oral cavity tumors. This evidence concerns the gene ELAVL1 and oral cavity neoplasm.